TAM
AMAG

Tocqueville Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Tocqueville Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-242,250
Closed -$4.88M – 867
2018
Q1 		$4.88M Buy
242,250
+28,100
+13% +$475K 0.06% 305
2017
Q4 		$2.84M Sell
214,150
-360
-0.2% -$5.43K 0.03% 396
2017
Q3 		$3.96M Buy
+214,510
New +$4M 0.05% 354

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tocqueville Asset Management's AMAG Position: Q2 2018 in Review

Tocqueville Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2018, closing a stake of 242,250 shares — an estimated $4.88M sold.

Tocqueville Asset Management first reported a position in AMAG in Q3 2017 and held it in 3 quarters. The position peaked at $4.88M in Q1 2018. 173 funds tracked by Wall St. Rank hold AMAG as of Q2 2018.

  • Tocqueville Asset Management reported no remaining AMAG Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Tocqueville Asset Management sold 242,250 AMAG Pharmaceuticals shares in Q2 2018, an estimated $4.88M.
  • Tocqueville Asset Management first reported a position in AMAG Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • Tocqueville Asset Management's AMAG Pharmaceuticals position peaked at $4.88M in Q1 2018.
  • 173 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2018.

Based on Tocqueville Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.